BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31927027)

  • 1. Postplacental placement of intrauterine devices: A randomized clinical trial.
    Laporte M; Marangoni M; Surita F; Juliato CT; Miadaira M; Bahamondes L
    Contraception; 2020 Mar; 101(3):153-158. PubMed ID: 31927027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow up on post-placental IUD insertion: A randomized clinical trial.
    Marangoni M; Laporte M; Surita F; Kraft MB; Bahamondes L; Juliato CRT
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):596-603. PubMed ID: 33421091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery.
    Gurney EP; Sonalkar S; McAllister A; Sammel MD; Schreiber CA
    Am J Obstet Gynecol; 2018 Aug; 219(2):183.e1-183.e9. PubMed ID: 29870737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial.
    Whitaker AK; Endres LK; Mistretta SQ; Gilliam ML
    Contraception; 2014 Jun; 89(6):534-9. PubMed ID: 24457061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial.
    Chen BA; Reeves MF; Hayes JL; Hohmann HL; Perriera LK; Creinin MD
    Obstet Gynecol; 2010 Nov; 116(5):1079-87. PubMed ID: 20966692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postplacental intrauterine device expulsion by 12 weeks: a prospective cohort study.
    Goldthwaite LM; Sheeder J; Hyer J; Tocce K; Teal SB
    Am J Obstet Gynecol; 2017 Dec; 217(6):674.e1-674.e8. PubMed ID: 28826801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with missing strings and expulsion after postplacental insertion of copper T380A intrauterine devices.
    da Silva Nóbrega AB; Pitangui ACR; Vieira CS
    Int J Gynaecol Obstet; 2022 Apr; 157(1):67-75. PubMed ID: 34197636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
    PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate postpartum insertion of intrauterine device for contraception.
    Lopez LM; Bernholc A; Hubacher D; Stuart G; Van Vliet HA
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003036. PubMed ID: 26115018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of the endometrial cavity and intrauterine contraceptive device expulsion.
    Bahamondes MV; Monteiro I; Canteiro R; Fernandes Ados S; Bahamondes L
    Int J Gynaecol Obstet; 2011 Apr; 113(1):50-3. PubMed ID: 21272883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis.
    Averbach SH; Ermias Y; Jeng G; Curtis KM; Whiteman MK; Berry-Bibee E; Jamieson DJ; Marchbanks PA; Tepper NK; Jatlaoui TC
    Am J Obstet Gynecol; 2020 Aug; 223(2):177-188. PubMed ID: 32142826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
    Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
    Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes.
    Zerden ML; Stuart GS; Charm S; Bryant A; Garrett J; Morse J
    Contraception; 2017 Jan; 95(1):65-70. PubMed ID: 27554014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.